Applied Clinical Trials
Automation will be key to improving efficiency and mitigating risk during the complex process of cell therapy production and delivery.
Rolf Ehrhardt
Advertisement
Rolf Ehrhardt, MD, PhD is CEO of MedCision.
Articles by Rolf Ehrhardt
Applied Clinical Trials
In this article, MedCision executive discusses cell therapies.
Advertisement
Latest Updated Articles
- The Success of Cell Therapies Will Depend on Automation
July 14th 2017
The Success of Cell Therapies Will Depend on AutomationOctober 1st 2017
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The 10 Most Powerful Study KRIs in RBQM and GCP Issues They Can Prevent
2
ACT Brief: APAC Inspection Findings, RBQM Key Risk Indicators, and Head and Neck Cancer Approval
3
AI Can Draft the CSR Faster, But Does That Make Drug Development Faster?
4
How China Cut Its Phase III Startup Timeline and What Drove the Change
5